Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica
In this work, we describe the clinical and instrumental results of our experience, the first reported in the literature, of the administration of teriparatide to treat severe osteoporosis secondary to epidermolysis bullosa. Already after 2 months of therapy, the patient, a 20-year-old affected by a...
Gespeichert in:
| Veröffentlicht in: | Osteoporosis international 2011-03, Vol.22 (3), p.1003-1006 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1006 |
|---|---|
| container_issue | 3 |
| container_start_page | 1003 |
| container_title | Osteoporosis international |
| container_volume | 22 |
| creator | Moretti, L Notarnicola, A Panella, A Garofalo, L Garofalo, R Santamato, A Moretti, B |
| description | In this work, we describe the clinical and instrumental results of our experience, the first reported in the literature, of the administration of teriparatide to treat severe osteoporosis secondary to epidermolysis bullosa. Already after 2 months of therapy, the patient, a 20-year-old affected by a recessive form of epidermolysis bullosa dystrophica, had less pain and a functional recovery resulting in an improved autonomy; a satisfactory increase in the densitometric values was documented. |
| doi_str_mv | 10.1007/s00198-010-1278-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954597954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>850564905</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-a89fa4d324725a44cf380a74740316835fe96484bd1666bceda2c6e9d9d4a6513</originalsourceid><addsrcrecordid>eNqFkUtv1TAQhSMEoreFH8AGLCTEKuB34iWqoCBVYlEqsbMmzqR1lRsH2ym6_x5HuVCJBWz8kL9zxjOnql4w-o5R2rxPlDLT1pTRmvGmrfmjasekEDU3Wj2udtSIpjaSfT-pTlO6o0VjTPO0OuFUqlZps6viFd5jRBJSxjCHGJJPJEeEjD356fMtyRj9DBGy75H4iQCZyxmnTGAY0K1cdyARHabk75HgXMC4D-NhteqWcQwJSH9IOYb51jt4Vj0ZYEz4_LifVdefPn47_1xffr34cv7hsnZS6VxDawaQveCy4QqkdINoKTSykVQw3Qo1oNGylV3PtNadwx6402h600vQiomz6u3mO8fwY8GU7d4nh-MIE4YlWaOkMk1Z_0u2iiotDVWFfP0XeReWOJU2bCuN5poaUyC2Qa6MM0Uc7Bz9HuLBMmrX4OwWnKXrvQRnedG8PBov3R77P4rfSRXgzRGA5GAcIkzOpwdOGFoGtfbCNy6Vp-kG48MP_1X91SYaIFi4icX4-opTJgooqeFc_AJrt7qs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>849626099</pqid></control><display><type>article</type><title>Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Moretti, L ; Notarnicola, A ; Panella, A ; Garofalo, L ; Garofalo, R ; Santamato, A ; Moretti, B</creator><creatorcontrib>Moretti, L ; Notarnicola, A ; Panella, A ; Garofalo, L ; Garofalo, R ; Santamato, A ; Moretti, B</creatorcontrib><description>In this work, we describe the clinical and instrumental results of our experience, the first reported in the literature, of the administration of teriparatide to treat severe osteoporosis secondary to epidermolysis bullosa. Already after 2 months of therapy, the patient, a 20-year-old affected by a recessive form of epidermolysis bullosa dystrophica, had less pain and a functional recovery resulting in an improved autonomy; a satisfactory increase in the densitometric values was documented.</description><identifier>ISSN: 0937-941X</identifier><identifier>EISSN: 1433-2965</identifier><identifier>DOI: 10.1007/s00198-010-1278-2</identifier><identifier>PMID: 20458569</identifier><language>eng</language><publisher>London: London : Springer-Verlag</publisher><subject>Biological and medical sciences ; Bone Density - drug effects ; Bone Density Conservation Agents - therapeutic use ; Bullous diseases of the skin ; Case Report ; densitometry ; Dermatology ; Diseases of the osteoarticular system ; Drug therapy ; Endocrinology ; Epidermolysis bullosa ; Epidermolysis Bullosa Dystrophica - complications ; Female ; Genetic disorders ; Humans ; Medical sciences ; Medicine ; Medicine & Public Health ; Orthopedics ; Osteoporosis ; Osteoporosis - complications ; Osteoporosis - drug therapy ; Osteoporosis - rehabilitation ; Osteoporosis. Osteomalacia. Paget disease ; Rheumatology ; Teriparatide ; Teriparatide - therapeutic use ; Young Adult</subject><ispartof>Osteoporosis international, 2011-03, Vol.22 (3), p.1003-1006</ispartof><rights>International Osteoporosis Foundation and National Osteoporosis Foundation 2010</rights><rights>2015 INIST-CNRS</rights><rights>International Osteoporosis Foundation and National Osteoporosis Foundation 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-a89fa4d324725a44cf380a74740316835fe96484bd1666bceda2c6e9d9d4a6513</citedby><cites>FETCH-LOGICAL-c456t-a89fa4d324725a44cf380a74740316835fe96484bd1666bceda2c6e9d9d4a6513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00198-010-1278-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00198-010-1278-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23904724$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20458569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moretti, L</creatorcontrib><creatorcontrib>Notarnicola, A</creatorcontrib><creatorcontrib>Panella, A</creatorcontrib><creatorcontrib>Garofalo, L</creatorcontrib><creatorcontrib>Garofalo, R</creatorcontrib><creatorcontrib>Santamato, A</creatorcontrib><creatorcontrib>Moretti, B</creatorcontrib><title>Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica</title><title>Osteoporosis international</title><addtitle>Osteoporos Int</addtitle><addtitle>Osteoporos Int</addtitle><description>In this work, we describe the clinical and instrumental results of our experience, the first reported in the literature, of the administration of teriparatide to treat severe osteoporosis secondary to epidermolysis bullosa. Already after 2 months of therapy, the patient, a 20-year-old affected by a recessive form of epidermolysis bullosa dystrophica, had less pain and a functional recovery resulting in an improved autonomy; a satisfactory increase in the densitometric values was documented.</description><subject>Biological and medical sciences</subject><subject>Bone Density - drug effects</subject><subject>Bone Density Conservation Agents - therapeutic use</subject><subject>Bullous diseases of the skin</subject><subject>Case Report</subject><subject>densitometry</subject><subject>Dermatology</subject><subject>Diseases of the osteoarticular system</subject><subject>Drug therapy</subject><subject>Endocrinology</subject><subject>Epidermolysis bullosa</subject><subject>Epidermolysis Bullosa Dystrophica - complications</subject><subject>Female</subject><subject>Genetic disorders</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Orthopedics</subject><subject>Osteoporosis</subject><subject>Osteoporosis - complications</subject><subject>Osteoporosis - drug therapy</subject><subject>Osteoporosis - rehabilitation</subject><subject>Osteoporosis. Osteomalacia. Paget disease</subject><subject>Rheumatology</subject><subject>Teriparatide</subject><subject>Teriparatide - therapeutic use</subject><subject>Young Adult</subject><issn>0937-941X</issn><issn>1433-2965</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkUtv1TAQhSMEoreFH8AGLCTEKuB34iWqoCBVYlEqsbMmzqR1lRsH2ym6_x5HuVCJBWz8kL9zxjOnql4w-o5R2rxPlDLT1pTRmvGmrfmjasekEDU3Wj2udtSIpjaSfT-pTlO6o0VjTPO0OuFUqlZps6viFd5jRBJSxjCHGJJPJEeEjD356fMtyRj9DBGy75H4iQCZyxmnTGAY0K1cdyARHabk75HgXMC4D-NhteqWcQwJSH9IOYb51jt4Vj0ZYEz4_LifVdefPn47_1xffr34cv7hsnZS6VxDawaQveCy4QqkdINoKTSykVQw3Qo1oNGylV3PtNadwx6402h600vQiomz6u3mO8fwY8GU7d4nh-MIE4YlWaOkMk1Z_0u2iiotDVWFfP0XeReWOJU2bCuN5poaUyC2Qa6MM0Uc7Bz9HuLBMmrX4OwWnKXrvQRnedG8PBov3R77P4rfSRXgzRGA5GAcIkzOpwdOGFoGtfbCNy6Vp-kG48MP_1X91SYaIFi4icX4-opTJgooqeFc_AJrt7qs</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>Moretti, L</creator><creator>Notarnicola, A</creator><creator>Panella, A</creator><creator>Garofalo, L</creator><creator>Garofalo, R</creator><creator>Santamato, A</creator><creator>Moretti, B</creator><general>London : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20110301</creationdate><title>Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica</title><author>Moretti, L ; Notarnicola, A ; Panella, A ; Garofalo, L ; Garofalo, R ; Santamato, A ; Moretti, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-a89fa4d324725a44cf380a74740316835fe96484bd1666bceda2c6e9d9d4a6513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biological and medical sciences</topic><topic>Bone Density - drug effects</topic><topic>Bone Density Conservation Agents - therapeutic use</topic><topic>Bullous diseases of the skin</topic><topic>Case Report</topic><topic>densitometry</topic><topic>Dermatology</topic><topic>Diseases of the osteoarticular system</topic><topic>Drug therapy</topic><topic>Endocrinology</topic><topic>Epidermolysis bullosa</topic><topic>Epidermolysis Bullosa Dystrophica - complications</topic><topic>Female</topic><topic>Genetic disorders</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Orthopedics</topic><topic>Osteoporosis</topic><topic>Osteoporosis - complications</topic><topic>Osteoporosis - drug therapy</topic><topic>Osteoporosis - rehabilitation</topic><topic>Osteoporosis. Osteomalacia. Paget disease</topic><topic>Rheumatology</topic><topic>Teriparatide</topic><topic>Teriparatide - therapeutic use</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moretti, L</creatorcontrib><creatorcontrib>Notarnicola, A</creatorcontrib><creatorcontrib>Panella, A</creatorcontrib><creatorcontrib>Garofalo, L</creatorcontrib><creatorcontrib>Garofalo, R</creatorcontrib><creatorcontrib>Santamato, A</creatorcontrib><creatorcontrib>Moretti, B</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Osteoporosis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moretti, L</au><au>Notarnicola, A</au><au>Panella, A</au><au>Garofalo, L</au><au>Garofalo, R</au><au>Santamato, A</au><au>Moretti, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica</atitle><jtitle>Osteoporosis international</jtitle><stitle>Osteoporos Int</stitle><addtitle>Osteoporos Int</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>22</volume><issue>3</issue><spage>1003</spage><epage>1006</epage><pages>1003-1006</pages><issn>0937-941X</issn><eissn>1433-2965</eissn><abstract>In this work, we describe the clinical and instrumental results of our experience, the first reported in the literature, of the administration of teriparatide to treat severe osteoporosis secondary to epidermolysis bullosa. Already after 2 months of therapy, the patient, a 20-year-old affected by a recessive form of epidermolysis bullosa dystrophica, had less pain and a functional recovery resulting in an improved autonomy; a satisfactory increase in the densitometric values was documented.</abstract><cop>London</cop><pub>London : Springer-Verlag</pub><pmid>20458569</pmid><doi>10.1007/s00198-010-1278-2</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0937-941X |
| ispartof | Osteoporosis international, 2011-03, Vol.22 (3), p.1003-1006 |
| issn | 0937-941X 1433-2965 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_954597954 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Biological and medical sciences Bone Density - drug effects Bone Density Conservation Agents - therapeutic use Bullous diseases of the skin Case Report densitometry Dermatology Diseases of the osteoarticular system Drug therapy Endocrinology Epidermolysis bullosa Epidermolysis Bullosa Dystrophica - complications Female Genetic disorders Humans Medical sciences Medicine Medicine & Public Health Orthopedics Osteoporosis Osteoporosis - complications Osteoporosis - drug therapy Osteoporosis - rehabilitation Osteoporosis. Osteomalacia. Paget disease Rheumatology Teriparatide Teriparatide - therapeutic use Young Adult |
| title | Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T07%3A32%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20osteoporosis%20treated%20with%20teriparatide%20in%20a%20patient%20affected%20by%20recessive%20epidermolysis%20bullosa%20dystrophica&rft.jtitle=Osteoporosis%20international&rft.au=Moretti,%20L&rft.date=2011-03-01&rft.volume=22&rft.issue=3&rft.spage=1003&rft.epage=1006&rft.pages=1003-1006&rft.issn=0937-941X&rft.eissn=1433-2965&rft_id=info:doi/10.1007/s00198-010-1278-2&rft_dat=%3Cproquest_cross%3E850564905%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=849626099&rft_id=info:pmid/20458569&rfr_iscdi=true |